Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: May 6, 2001
Last updated: March 5, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: July 2003 (Final data collection date for primary outcome measure)